Sanguine Expands Oncology Biospecimen Offerings Through Strategic Clinic Partnerships

Driving Cancer Discovery with Minimally Invasive, Treatment-Naive Samples SAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Sanguine Biosciences, a leading provider of healthy and disease-state human biospecimens and data for research, today announced the expansion of its oncology sample...